Lund Melanoma Study Group
121 – 130 of 245
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Clinical protein science in translational medicine targeting malignant melanoma
(
- Contribution to journal › Article
-
Mark
Improved survival prognostication of node-positive malignant melanoma patients utilizing shotgun proteomics guided by histopathological characterization and genomic data
(
- Contribution to journal › Article
-
Mark
Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer
(
- Contribution to journal › Article
-
Mark
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
(
- Contribution to journal › Article
-
Mark
Genetic data from nearly 63,000 women of European descent predicts DNA methylation biomarkers and epithelial ovarian cancer risk
(
- Contribution to journal › Article
-
Mark
Risk factors for subarachnoid haemorrhage : a nationwide cohort of 950 000 adults
(
- Contribution to journal › Article
-
Mark
Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets
(
- Contribution to journal › Article
-
Mark
2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm : long-term follow-up of a multicentre, randomised trial
(
- Contribution to journal › Article
-
Mark
The impact of body size changes on recurrence risk depends on age and estrogen receptor status in primary breast cancer
(
- Contribution to journal › Article
-
Mark
Survival benefits from concomitant chemoradiotherapy before radical surgery in stage IVA sinonasal mucosal melanoma?
(
- Contribution to journal › Article